1. Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms.
- Author
-
Zhang, Peiwen, You, Na, Ding, Yiyi, Zhu, Wenqi, Wang, Nan, Xie, Yueqiao, Huang, Wanling, Ren, Qian, Qin, Tiejun, Fu, Rongfeng, Zhang, Lei, Xiao, Zhijian, Cheng, Tao, and Ma, Xiaotong
- Subjects
MYELOPROLIFERATIVE neoplasms ,HEMATOPOIETIC stem cells ,HEMATOPOIETIC system ,GENETIC mutation ,PATHOGENESIS - Abstract
Despite the identification of driver mutations leading to the initiation of myeloproliferative neoplasms (MPNs), the molecular pathogenesis of MPNs remains incompletely understood. Here, we demonstrate that growth arrest and DNA damage inducible gamma (GADD45g) is expressed at significantly lower levels in patients with MPNs, and JAK2V617F mutation and histone deacetylation contribute to its reduced expression. Downregulation of GADD45g plays a tumor-promoting role in human MPN cells. Gadd45g insufficiency in the murine hematopoietic system alone leads to significantly enhanced growth and self-renewal capacity of myeloid-biased hematopoietic stem cells, and the development of phenotypes resembling MPNs. Mechanistically, the pathogenic role of GADD45g insufficiency is mediated through a cascade of activations of RAC2, PAK1 and PI3K-AKT signaling pathways. These data characterize GADD45g deficiency as a novel pathogenic factor in MPNs. Different gene mutations have been reported as drivers for myeloproliferative neoplasms (MPN). Here, the authors show that Gadd45g insufficiency induces MPN in mouse models and associates with MPN in patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF